Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
April 20 2022 - 8:06AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2022
Commission File Number: 001-39530
ImmunoPrecise
Antibodies Ltd.
(Translation of registrant’s name into English)
3204 - 4464 Markham Street, Victoria, British Columbia V8Z 7X8
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐ Form 40-F ☒
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
EXHIBIT INDEX
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
IMMUNOPRECISE ANTIBODIES LTD.
|
|
|
|
|
Date: April 20, 2022
|
|
By:
|
/s/ Lisa Helbling
|
|
|
|
Lisa Helbling
|
|
|
|
Chief Financial Officer
|
ImmunoPrecise Antibodies (NASDAQ:IPA)
Historical Stock Chart
From Sep 2024 to Oct 2024
ImmunoPrecise Antibodies (NASDAQ:IPA)
Historical Stock Chart
From Oct 2023 to Oct 2024